The company is also advancing commercial preparations for COMP360 in treatment-resistant depression (TRD), aiming to be ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic ...

Compass Pathways (CMPS), on Wednesday, said the U.S. Food and Drug Administration (FDA) has accepted its Investigational New ...

Shares of Compass Pathways Plc (NASDAQ:CMPS) rose about 3% in premarket trading on Wednesday after the company said the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND ...

Compass Pathways has entered its seventh U.S. strategic collaboration with Radial Health. Radial Health operates in five ...

LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS” or the “company”), a biotechnology company dedicated to accelerating patient access to evidence-based ...

Compass Pathways reported operating expenses of $48.4 million, slightly above Canaccord's estimate of $48 million. Kulkarni highlighted that Compass Pathways is nearing completion of its COMP005 Phase ...

Maxim Group analyst Jason McCarthy has maintained their bullish stance on CMPS stock, giving a Buy rating today. Jason McCarthy’s Buy rating for COMPASS Pathways is influenced by several factors.

With timelines for the submission of approval for MDMA-assisted therapy becoming more clear, COMPASS Pathways CMPS has provided their own estimation on when psilocybin-assisted therapy may obtain ...

In other recent news, Compass Pathways has been making significant strides in its operations and development programs. RBC Capital initiated coverage on Compass Pathways shares, assigning an ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20251104736485/en/ ...